Catalyst Wire Dossier Catalyst Wire Dossier

Targeted Anti-CEA CAR-T Immunotherapy

· Chongqing Precision Biotech Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Targeted Anti-CEA CAR-T Immunotherapy, covering 2025-05-28 to 2025-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer [Phase 1]

See pricing